SEC Form 4 · accession 0001209191-15-052059
Calithera Biosciences, Inc. · CALA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Deepika Pakianathan
Director · 10% Owner
Period of report
Jun 9, 2015
Accepted (ET)
Jun 10, 2015 · 8:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F1 | $7.99 | Jun 9, 2015 | A | 11,000 | A | — | Jun 8, 2025 | Common Stock | 11,000 | 11,000 | D |
Explanation of responses
- F11/12 of the Option vests in each monthly installment as measured from June 9, 2015, until the earlier of the Option's full vesting or the reporting person ceasing to provide continuous service to the issuer. In addition, in the event of a Change of Control or a Corporate Transaction (each as defined in the 2014 Plan pursuant to which the Option was granted), any unvested portion of the Option will fully vest and become exercisable as of immediately prior to the effective time of such Change of Control or Corporate Transaction, subject to the reporting person's continuous service on the effective date of the Change of Control or Corporate Transaction.
- F2Pursuant to the Delphi Management Partners, VIII, L.L.C. ("DMP VIII") LLC Agreement, the Reporting Person is deemed to hold the options for the benefit of DMP VIII, which is entitled to hold the shares upon issuance. DMP VIII may be deemed the indirect beneficial owner of such shares, and the Reporting Person is a managing member of DMP VIII and may be deemed to share voting and dispositive power over shares held by DMP VIII. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.